{"code":"HSC","codeName":"Health and Safety Code","section":"127694.1","citation":"Health & Saf. Code, § 127694.1","status":"in-force","lawOn":"2026-09-28","headings":[{"name":"DIVISION 107. HEALTH CARE ACCESS AND INFORMATION [127000. - 130079.]","url":"https://blackletter.si/health-and-safety-code/division-107"},{"name":"PART 2. HEALTH POLICY AND PLANNING [127280. - 127774.]","url":"https://blackletter.si/health-and-safety-code/division-107/part-2"},{"name":"CHAPTER 10. California Affordable Drug Manufacturing Act of 2020 [127690. - 127697.]","url":"https://blackletter.si/health-and-safety-code/division-107/part-2/chapter-10"}],"history":"Added by Stats. 2022, Ch. 603, Sec. 3.   (SB 838)   Effective January 1, 2023.","effective":"2023-01-01","html":"<p>Upon appropriation by the Legislature, CHHSA shall develop a California-based manufacturing facility for insulin, with the intent of creating high-skill, high-paying jobs with the state. The facility shall be at a location jointly determined between the state and the partner pursuant to Section <a href=\"/hsc/127692\">127692</a>.</p>","text":"Upon appropriation by the Legislature, CHHSA shall develop a California-based manufacturing facility for insulin, with the intent of creating high-skill, high-paying jobs with the state. The facility shall be at a location jointly determined between the state and the partner pursuant to Section 127692.","otherVersions":[],"url":"https://blackletter.si/health-and-safety-code/california-affordable-drug-manufacturing-act-of-2020-127694-1","source":"California Legislative Information bulk export (pubinfo)"}